Nautilus Biotechnology, Inc.·4

Jun 2, 5:12 PM ET

Mowry Anna 4

4 · Nautilus Biotechnology, Inc. · Filed Jun 2, 2025

Insider Transaction Report

Form 4
Period: 2025-05-29
Mowry Anna
CFO and Treasurer
Transactions
  • Purchase

    Common Stock

    2025-05-29$0.77/sh+15,000$11,48983,000 total
Footnotes (2)
  • [F1]Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.7662 to $0.7489 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Includes the following shares of Common Stock acquired through the Issuer's 2021 Employee Stock Purchase Plan: (i) 1,250 shares on December 1, 2022; (ii) 1,250 shares on June 1, 2023; (iii) 1,250 shares on December 1, 2023; (iv) 2,500 shares on May 31, 2024; (v) 2,500 shares on November 29, 2024; and (vi) 2,500 shares on May 30, 2025.

Documents

1 file
  • 4
    wk-form4_1748898746.xmlPrimary

    FORM 4